Accelerate Diagnostics
AXDX
AXDX was delisted on the 14th of May, 2025.
47 hedge funds and large institutions have $106M invested in Accelerate Diagnostics in 2013 Q3 according to their latest regulatory filings, with 7 funds opening new positions, 25 increasing their positions, 6 reducing their positions, and 7 closing their positions.
317% more repeat investments, than reductions
Existing positions increased: 25 | Existing positions reduced: 6
90% more capital invested
Capital invested by funds: $55.9M → $106M (+$50.3M)
0% more funds holding
Funds holding: 47 → 47 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 7
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
OIM
Oracle Investment Management
Greenwich,
Connecticut
|
+$4.59M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$3.62M |
| 3 |
Northern Trust
Chicago,
Illinois
|
+$926K |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$838K |
| 5 |
State Street
Boston,
Massachusetts
|
+$703K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CII
CR Intrinsic Investors
Stamford,
Connecticut
|
-$1.48M |
| 2 |
PA
Para Advisors
New York
|
-$528K |
| 3 |
Morgan Stanley
New York
|
-$311K |
| 4 |
Boston Partners
Boston,
Massachusetts
|
-$300K |
| 5 |
Goldman Sachs
New York
|
-$282K |
AXDX Hedge Fund Activity: Q3 2013 in Review
47 of the 3,096 institutional investors tracked by Wall St. Rank reported a position in Accelerate Diagnostics (AXDX) for Q3 2013, worth a combined $106M — up 90% from $55.9M a quarter earlier.
Fund positioning in AXDX was balanced in Q3 2013: 7 funds opened new positions, 7 closed out, 25 added to existing stakes and 6 trimmed.
The largest buyer was Oracle Investment Management, adding an estimated $4.59M. The largest seller was CR Intrinsic Investors, exiting entirely with an estimated $1.48M sold.
- 47 institutional investors held Accelerate Diagnostics (AXDX) as of Q3 2013, unchanged from Q2 2013.
- Funds reported $106M of Accelerate Diagnostics stock for Q3 2013, up 90% quarter-over-quarter.
- 7 funds opened new Accelerate Diagnostics positions in Q3 2013 and 7 closed out, a net change of 0 holders.
- The largest Accelerate Diagnostics buyer in Q3 2013 was Oracle Investment Management, an estimated $4.59M added.
- The largest Accelerate Diagnostics seller in Q3 2013 was CR Intrinsic Investors, an estimated $1.48M sold.
Based on aggregated 13F filings for Q3 2013.